Literature DB >> 17569974

Imaging findings of bisphosphonate-associated osteonecrosis of the jaws.

P M Phal1, R W T Myall, L A Assael, J L Weissman.   

Abstract

BACKGROUND AND
PURPOSE: Bisphosphonates are drugs that decrease bone turnover by inhibiting osteoclast activity. An association between the use of bisphosphonates and osteonecrosis of the maxilla and mandible has recently been described. This study describes the imaging findings of bisphosphonate-associated osteonecrosis of the jaws.
MATERIALS AND METHODS: This is a retrospective series of 15 clinically diagnosed patients, identified at 3 centers. Eleven patients were women, of whom 6 had breast cancer, 3 had osteoporosis, and 2 had multiple myeloma. Of the 4 male patients, 2 had prostate cancer, 1 had multiple myeloma, and 1 had osteoporosis. The age range of the patients was 52-85 years (average, 68 years). The mandible was the clinical site of involvement in 11 patients, and the maxilla was involved in 4 patients. Imaging consisted of orthopantomograms in 14 patients, CT scans in 5 patients, and radionuclide bone scan in 1 patient. Nine patients had sequential imaging. Two radiologists reviewed the images.
RESULTS: All of the patients had a degree of osseous sclerosis, most commonly involving the alveolar margin, but lamina dura thickening and full-thickness sclerosis were also observed. The sclerotic change encroached on the mandibular canal in 3 patients. Less commonly encountered findings included poorly healing or nonhealing extraction sockets, periapical lucencies, widening of the periodontal ligament space, osteolysis, sequestra, oroantral fistula, soft tissue thickening, and periosteal new bone formation.
CONCLUSIONS: The most common finding in bisphosphonate-associated osteonecrosis was osseous sclerosis. This varied from subtle thickening of the lamina dura and alveolar crest to attenuated osteopetrosis-like sclerosis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17569974      PMCID: PMC8134141          DOI: 10.3174/ajnr.A0518

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   3.825


  25 in total

1.  Bisphosphonate-induced osteopetrosis.

Authors:  Michael P Whyte; Deborah Wenkert; Karen L Clements; William H McAlister; Steven Mumm
Journal:  N Engl J Med       Date:  2003-07-31       Impact factor: 91.245

2.  Bisphosphonate-associated osteonecrosis of the auditory canal.

Authors:  Mark N Polizzotto; Vincent Cousins; Anthony P Schwarer
Journal:  Br J Haematol       Date:  2006-01       Impact factor: 6.998

3.  Bisphosphonates and osteonecrosis: analogy to phossy jaw.

Authors:  A Michael Donoghue
Journal:  Med J Aust       Date:  2005-08-01       Impact factor: 7.738

4.  Phosphorus necrosis of the jaw: 'phossy jaw'.

Authors:  A E Miles
Journal:  Br Dent J       Date:  1972-09       Impact factor: 1.626

5.  Bisphosphonate-associated osteonecrosis of mandibular and maxillary bone: an emerging oral complication of supportive cancer therapy.

Authors:  Cesar A Migliorati; Mark M Schubert; Douglas E Peterson; Luis Marcelo Seneda
Journal:  Cancer       Date:  2005-07-01       Impact factor: 6.860

6.  Bisphosphonate-induced exposed bone (osteonecrosis/osteopetrosis) of the jaws: risk factors, recognition, prevention, and treatment.

Authors:  Robert E Marx; Yoh Sawatari; Michel Fortin; Vishtasb Broumand
Journal:  J Oral Maxillofac Surg       Date:  2005-11       Impact factor: 1.895

Review 7.  Avascular jaw osteonecrosis in association with cancer chemotherapy: series of 10 cases.

Authors:  J V Bagan; J Murillo; Y Jimenez; R Poveda; M A Milian; J M Sanchis; F J Silvestre; C Scully
Journal:  J Oral Pathol Med       Date:  2005-02       Impact factor: 4.253

8.  Potential role of proinflammatory cytokines in nerve damage related bone loss.

Authors:  Andrew M Miesse; Jeffrey S Willey; Ted A Bateman
Journal:  Biomed Sci Instrum       Date:  2004

9.  Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic.

Authors:  Robert E Marx
Journal:  J Oral Maxillofac Surg       Date:  2003-09       Impact factor: 1.895

10.  Osteonecrosis of the jaws associated with the use of bisphosphonates: a review of 63 cases.

Authors:  Salvatore L Ruggiero; Bhoomi Mehrotra; Tracey J Rosenberg; Stephen L Engroff
Journal:  J Oral Maxillofac Surg       Date:  2004-05       Impact factor: 1.895

View more
  45 in total

Review 1.  Osteonecrosis of the jaw induced by clodronate, an alkylbiphosphonate: case report and literature review.

Authors:  Sabrina Crépin; Marie-Laure Laroche; Bernard Sarry; Louis Merle
Journal:  Eur J Clin Pharmacol       Date:  2010-05-01       Impact factor: 2.953

2.  Skeletal imaging effects of pamidronate therapy in osteosarcoma patients.

Authors:  Anita P Price; Sara J Abramson; Sinchun Hwang; Alexander Chou; Roger Bartolotta; Paul Meyers; Douglas S Katz
Journal:  Pediatr Radiol       Date:  2010-10-30

3.  Fractal dimension evaluation of cone beam computed tomography in patients with bisphosphonate-associated osteonecrosis.

Authors:  S R Torres; C S K Chen; B G Leroux; P P Lee; L G Hollender; M M Schubert
Journal:  Dentomaxillofac Radiol       Date:  2011-12       Impact factor: 2.419

4.  Bisphosphonate-related osteonecrosis of the jaw: position paper from the Allied Task Force Committee of Japanese Society for Bone and Mineral Research, Japan Osteoporosis Society, Japanese Society of Periodontology, Japanese Society for Oral and Maxillofacial Radiology, and Japanese Society of Oral and Maxillofacial Surgeons.

Authors:  Toshiyuki Yoneda; Hiroshi Hagino; Toshitsugu Sugimoto; Hiroaki Ohta; Shunji Takahashi; Satoshi Soen; Akira Taguchi; Satoru Toyosawa; Toshihiko Nagata; Masahiro Urade
Journal:  J Bone Miner Metab       Date:  2010-03-24       Impact factor: 2.626

5.  A retrospective study of digital subtraction technique to detect sclerotic changes in alveolar bone on intraoral radiographs of bisphosphonate-treated patients.

Authors:  M U Zaman; T Nakamoto; K Tanimoto
Journal:  Dentomaxillofac Radiol       Date:  2013-10-29       Impact factor: 2.419

6.  Panoramic radiographic features that predict the development of bisphosphonate-related osteonecrosis of the jaw.

Authors:  Ryota Kubo; Yoshiko Ariji; Tohru Taniguchi; Michihito Nozawa; Akitoshi Katsumata; Eiichiro Ariji
Journal:  Oral Radiol       Date:  2017-06-12       Impact factor: 1.852

7.  Periapical disease and bisphosphonates induce osteonecrosis of the jaws in mice.

Authors:  Ben Kang; Simon Cheong; Thawinee Chaichanasakul; Olga Bezouglaia; Elisa Atti; Sarah M Dry; Flavia Q Pirih; Tara L Aghaloo; Sotirios Tetradis
Journal:  J Bone Miner Res       Date:  2013-07       Impact factor: 6.741

8.  Bisphosphonate-related osteonecrosis of the jaw: clinical correlations with computerized tomography presentation.

Authors:  Sharon Elad; Moshe J Gomori; Noa Ben-Ami; Silvina Friedlander-Barenboim; Eran Regev; Towy S Lazarovici; Noam Yarom
Journal:  Clin Oral Investig       Date:  2009-07-15       Impact factor: 3.573

9.  Panoramic radiograph, computed tomography or magnetic resonance imaging. Which imaging technique should be preferred in bisphosphonate-associated osteonecrosis of the jaw? A prospective clinical study.

Authors:  Philipp Stockmann; Fabian M Hinkmann; Michael M Lell; Matthias Fenner; Eleftherios Vairaktaris; Friedrich-Wilhelm Neukam; Emeka Nkenke
Journal:  Clin Oral Investig       Date:  2009-06-10       Impact factor: 3.573

Review 10.  Multiple myeloma.

Authors:  Conor D Collins
Journal:  Cancer Imaging       Date:  2010-02-11       Impact factor: 3.909

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.